Sales & Marketing

May 01, 2005
Pharmaceutical Executive
A new TV doctor show features the most loathsome pharmaceutical executive in recent memory. But in another important way, the show is serving pharma's best interests.
May 01, 2005
Pharmaceutical Executive
A recently released report claims pharma hides bad clinical trial results and over-promotes drugs. Tougher regs are being called for.
Apr 01, 2005
Pharmaceutical Executive
The majority of headlines opposed the industry: 57.1 percent were negative, 18.1 percent were positive, and 24.8 percent were neutral. But the headlines were less negative than the stories themselves.
Apr 01, 2005
Pharmaceutical Executive
Could it be that someone's finally going to wipe the grin off Smiling Bob's face? As we were putting this issue to bed, the Cincinnati newspapers reported that federal agents had raided the offices of Berkeley Premium Nutraceuticals, a company best known for its "natural male enhancement" pill, Enzyte, and for its repulsive television commercials starring Bob. The US Postal Service led the operation, which also included the FBI, IRS, and FDA. They froze bank accounts, sent employees home, and combed records, attempting to determine whether Berkeley, which has accumulated more than 5,000 complaints with the Cincinnati Better Business Bureau and the Ohio attorney general's office since 2001, had committed mail fraud.
Apr 01, 2005
Pharmaceutical Executive
By Pharmaceutical Executive Editors
World-class talent seeks its own level, so hiring companies should make sure that those involved in the interviewing process are strong employees who represent the company as leaders in their own rights.
Apr 01, 2005
Pharmaceutical Executive
In a bright airy office above fifth avenue in New York, Lynn O'Connor Vos is talking about topics dear to her heart: trust—and how pharma can regain it—the need to put physicians back in the center of pharmaceutical marketing, and reinvention, a theme in her own life and the core to her approach to business.
Mar 01, 2005
Pharmaceutical Executive
Should policy makers expect 90 percent of seniors to enroll in PDPs, or will 75 percent be enough? Will the program have to keep costs down to $400 billion a year, or will spending be linked to savings elsewhere?
Feb 01, 2005
Pharmaceutical Executive
As a reputation driver, ethical behavior has increased steadily in importance over the last three years.
Feb 01, 2005
Pharmaceutical Executive
Physicians give only 25 percent of samples to newly diagnosed patients, along with a prescription.
Feb 01, 2005
Pharmaceutical Executive
For companies that are prepared, Part D represents a great opportunity. For others, failing to react quickly enough could be a costly mistake.
native1_300x100
lorem ipsum